Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fisher & Paykel Healthcare Corporation Limited (FSPKF)
:FSPKF
RESEARCH TOOLSreports
Holding FSPKF?
Track your performance easily
Earnings Data
Report Date
May 21, 2025TBA Not Confirmed
Period Ending
2025 (Q4)Consensus EPS Forecast
―Last Year’s EPS
―Same Quarter Last Year
Moderate Buy
Based on 6 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 26, 2019
|% Change Since: -0.32%
|Next Earnings Date:Nov 25, 2018
Earnings Call Sentiment|Positive
The earnings call reflected strong financial growth, product expansion, and operational efficiency. Despite challenges from currency exchange impacts and potential tariff issues, the overall business performance was robust.Company Guidance
During the Fisher & Paykel Healthcare's first half results call for the 2025 financial year, the company reported an 18% increase in operating revenue to $951 million and a 43% rise in net profit after tax to $153 million, compared to the prior period. Key product launches, such as the 950 system and Airvo 3 in the U.S., contributed to these results. The hospital product group achieved a 21% revenue growth to $591 million, while the homecare segment saw a 14% increase to $359 million. The gross margin improved to 61.9%, with operating expenses growing by 11%. Guidance for the full year projects revenue between $1.9 billion and $2 billion, with net profit after tax ranging from $320 million to $370 million, considering the volatile nature of seasonal hospitalizations and potential impacts from flu, COVID-19, and RSV.Strong Financial Performance
Operating revenue for the half was $951 million, up 18% from the prior period, with net profit after tax rising 43% to $153 million.
Successful Product Launches
Launch of the 950 system and Airvo 3 in the US added momentum to the hospital business. The new Optiflow Duet cannula has been released in major markets.
Expansion in Homecare
Homecare operating revenue was up 14% to $359 million, with the Nova Micro mask and F&P Solo gaining positive feedback.
Operational Efficiency
Gross margin improved to 61.9%, up 141 basis points, due to overhead efficiency and continued work on efficiency and margin improvements.
New Manufacturing Site
The Guangzhou manufacturing site is now operational, following regulatory clearance, expanding production capacity.
---
Fisher & Paykel Healthcare Corporation Limited (FSPKF) Earnings, Revenues Date & History
FSPKF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
FSPKF Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 27, 2024 | $21.59 | $22.45 | +3.98% |
| Nov 28, 2023 | $13.37 | $14.34 | +7.26% |
| May 25, 2023 | $14.83 | $14.19 | -4.32% |
| Nov 28, 2022 | $12.39 | $13.49 | +8.88% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Fisher & Paykel Healthcare Corporation Limited (FSPKF) report earnings?
Fisher & Paykel Healthcare Corporation Limited (FSPKF) is schdueled to report earning on May 21, 2025, TBA Not Confirmed.
What is Fisher & Paykel Healthcare Corporation Limited (FSPKF) earnings time?
Fisher & Paykel Healthcare Corporation Limited (FSPKF) earnings time is at May 21, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is FSPKF EPS forecast?
Currently, no data Available
---